60 Participants Needed

Online Therapy for Gynecologic Cancer

(eSense-Cancer Trial)

NM
KM
Overseen ByKira McNamee
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of British Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how an online therapy program can address the sexual health needs of gynecologic cancer survivors. It tests two types of therapy: eSense-Cancer CBT (Cognitive Behavioral Therapy) and eSense-Cancer MBT (Mindfulness-Based Therapy), offered with or without a "navigator" (a support person). The goal is to determine if this online platform can assist survivors who live far away or face other obstacles to receiving treatment. Individuals who have had gynecologic cancer, experience sexual difficulties, and have internet access may be suitable for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could improve access to care for many survivors.

Will I have to stop taking my current medications?

The trial does not specify whether you need to stop taking your current medications. However, if you are in active treatment for cancer, you would not be eligible to participate.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that cognitive-behavioral therapy (CBT) and mindfulness-based therapy (MBT) are generally safe and well-tolerated. These therapies improve sexual health and well-being.

The eSense-Cancer program offers these therapies online. Although specific data on side effects for the online version is unavailable, these therapies have proven safe in other settings, so similar results are expected online.

As the eSense-Cancer program is neither a medication nor a surgical treatment, the risk of side effects is much lower. This makes it a safe option for those seeking to improve sexual health after gynecologic cancer.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments because eSense-Cancer CBT and MBT offer innovative online therapy options for individuals with gynecologic cancer. Unlike traditional in-person therapy, these digital platforms provide cognitive behavioral therapy (CBT) and mindfulness-based therapy (MBT) that can be accessed remotely, making it more convenient and accessible. A unique feature of this trial is the inclusion of a "navigator" who can support participants through the therapy, potentially enhancing the effectiveness of the treatment. This approach could redefine how psychological support is provided to cancer patients, offering personalized, flexible, and potentially more engaging mental health care solutions.

What evidence suggests that this trial's treatments could be effective for gynecologic cancer survivors?

This trial will compare the effectiveness of cognitive-behavioral therapy (CBT) and mindfulness-based therapy (MBT) in improving sexual health and well-being in women who have survived gynecologic cancer. Participants will be assigned to one of the treatment arms, either with or without support from a treatment "navigator." Research has shown that both CBT and MBT can improve emotional well-being and comfort in discussing sensitive issues. The benefits of these therapies have been observed to last even three months after the sessions ended. Both CBT and MBT have enhanced the overall quality of life for cancer survivors. These therapies are available online, making them more accessible for those who live far away or face other challenges in reaching treatment.24567

Who Is on the Research Team?

LA

Lori A Brotto, PhD, RPsych

Principal Investigator

University of British Columbia

KS

Kyle Stephenson, PhD, RPsych

Principal Investigator

Xavier University of Louisiana.

Are You a Good Fit for This Trial?

This trial is for individuals with a history of any gynecologic cancer who are experiencing sexual health concerns. Participants must be fluent in English, able to commit to an 8-16 week program, have reliable internet access, and be comfortable using online platforms.

Inclusion Criteria

Are fluent in English (eSense content is delivered in English)
My gender does not affect my eligibility.
I have or had gynecological cancer.
See 3 more

Exclusion Criteria

I have visual impairments that affect my ability to read or use online materials.
Have poorly managed anxiety or mood disorder (assessed using the degree of life interference evaluation at screening)
I am currently undergoing treatment for my cancer.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete baseline questionnaires and undergo a 4-week waiting period before a second baseline assessment

4 weeks

Treatment

Participants are randomized to one of four arms and complete 8 modules of CBT or MBT with or without navigator support

8-16 weeks
Weekly/biweekly online module completion

Post-Treatment Assessment

Participants complete post-treatment questionnaires to assess various feasibility dimensions and clinical outcomes

1-2 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • eSense-Cancer CBT
  • eSense-Cancer MBT
Trial Overview The study tests an adapted online intervention called eSense-Cancer aimed at addressing sexual health issues after gynecologic cancer. It involves navigator support and cognitive-behavioral therapy-based modules delivered over the web.
How Is the Trial Designed?
4Treatment groups
Active Control
Group I: CBT - No navigatorActive Control1 Intervention
Group II: MBT - No navigatorActive Control1 Intervention
Group III: CBT - NavigatorActive Control2 Interventions
Group IV: MBT - NavigatorActive Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of British Columbia

Lead Sponsor

Trials
1,506
Recruited
2,528,000+

Xavier University of Louisiana.

Collaborator

Trials
9
Recruited
2,700+

Published Research Related to This Trial

A pilot study involving 27 gynecologic cancer patients showed that a 12-week web-based support group focusing on sexuality-related topics was both feasible and well-accepted, providing significant emotional support and improved body image.
Participants reported benefits such as increased emotional well-being and comfort in discussing sensitive topics, highlighting the effectiveness of online support groups in addressing psychosexual distress among gynecologic cancer patients.
A qualitative study of an internet-based support group for women with sexual distress due to gynecologic cancer.Wiljer, D., Urowitz, S., Barbera, L., et al.[2022]
Internet-based cognitive behavioral therapy (iCBT) effectively reduces the perceived impact of hot flushes and night sweats in breast cancer survivors experiencing treatment-induced menopausal symptoms, based on a randomized controlled trial involving 235 women.
Women with lower education levels showed the most significant benefits from iCBT, and the development of healthier beliefs about hot flushes and their impact on daily life played a crucial role in the treatment's effectiveness.
Internet-based cognitive behavioral therapy aimed at alleviating treatment-induced menopausal symptoms in breast cancer survivors: Moderators and mediators of treatment effects.Atema, V., van Leeuwen, M., Kieffer, JM., et al.[2020]
The BPSS app, designed to support breast cancer patients during chemotherapy, did not show significant improvements in anxiety, depression, or health literacy compared to patients who did not use the app, based on a study of 102 patients.
Despite the lack of improvement in psychological outcomes, the app effectively recorded a high number of side effects, revealing that medical staff often underestimated the severity of patients' symptoms, suggesting the app could enhance communication and care between patients and healthcare providers.
Effectiveness of a Smartphone Application as a Support Tool for Patients Undergoing Breast Cancer Chemotherapy: A Randomized Controlled Trial.Handa, S., Okuyama, H., Yamamoto, H., et al.[2021]

Citations

eSense-Cancer: Adapting an Online Intervention for ...This research aims to assess how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors.
eSense-Cancer: Adapting an Online Intervention for ...This research aims to assess how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors and to ...
eSense Cancer | UBC Sexual Health ResearchOur research aims to assess how well eSense-Cancer, an adapted online health intervention, meets gynecologic cancer survivors' sexual health needs.
Online Therapy for Gynecologic Cancer (eSense-Cancer Trial)The eSense-Cancer online therapy is unique because it offers cognitive behavioral therapy (CBT) and mindfulness-based therapy (MBT) through an online platform, ...
Online Intervention for Sexual Health in Gynecologic CancerThis study aims to assess the effectiveness of an online program (eSense-Cancer) ... The program offers cognitive-behavioral therapy (CBT) or mindfulness-based ...
eSense-Cancer: Adapting an Online Intervention for ...This research aims to assess how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors and to test the ...
eSense-Cancer: Adapting an Online Intervention for Sexual ...This research aims to assess how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors and to ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security